Clinical Trials
9 trialsNCT02576431 2026-04-28
NAVIGATE
Bayer
Phase 2 Completed
NCT05694819 2026-04-08
Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)
National Cancer Center Hospital East
Phase 2 Completed
NCT00939627 2026-03-10
Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab
National Cancer Institute (NCI)
Phase 2 Completed
NCT02589938 2026-02-27
ACUPUNCTURE
Wake Forest University Health Sciences
Phase NA Completed
NCT02069730 2026-01-08
A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes
University Health Network, Toronto
Phase NA Completed
NCT03172624 2025-12-18
Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00954226 2025-09-05
Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT06582849 2025-08-26
EARN
Washington University School of Medicine
Phase NA Completed
NCT05581979 2025-07-25
PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers
National Cancer Centre, Singapore
Completed